New amfAR grants enlist help of bioengineers to overcome obstacles to curing HIV

NEW YORK, NY — In a novel approach to conquering HIV, amfAR, The Foundation for AIDS Research, is pairing HIV researchers with bioengineers to address the main barrier to a cure for HIV: the persistent reservoirs of virus not cleared by antiretroviral therapy. A new round of Investment grants, totaling $1.2 million, will support six…

Read More

amfAR study observes potential breakthrough in treatment of HIV

SAN FRANCISCO – A new study funded by amfAR, The Foundation for AIDS Research conducted by researchers at the San Francisco VA Medical Center (SFVAMC) observes that pharmacological enhancement of the immune systems of HIV patients could help eliminate infected cells, providing an important step in the ongoing quest to find a lasting HIV cure….

Read More

amfAR establishes San Francisco-based institute for HIV Cure Research

NEW YORK – amfAR, The Foundation for AIDS Research, today announced the establishment of the amfAR Institute for HIV Cure Research, an innovative collaborative enterprise based at UC San Francisco (UCSF). As the cornerstone of amfAR’s $100 million cure research investment strategy, the aim of the Institute will be to develop the scientific basis of…

Read More

New amfAR report highlights priority actions to help states achieve national HIV/AIDS strategy goals

NEW YORK – Major achievements have been made in the domestic HIV/AIDS response as a result of increased realignment and coordination of efforts at the federal level. However, that level of consistent coordination and alignment has yet to take place in most states. In an effort to identify what needs to be done, amfAR, The Foundation…

Read More

amfAR launches PEPFAR country/regional operational plan database

NEW YORK – amfAR, The Foundation for AIDS Research, today announced the beta launch of its PEPFAR Country/Regional Operational Plan database, a comprehensive, navigable database of PEPFAR’s planned funding of HIV/AIDS activities from 2007 to 2014. The database was unveiled at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015)…

Read More

New amfAR report warns of trade agreement’s potentially damaging effects on global public health

NEW YORK – The proposed Trans-Pacific Partnership (TPP), a free trade agreement currently being negotiated among 12 Pacific Rim countries, threatens the future availability of affordable generic medicines and could undermine the global HIV response in developing countries, according to a new report released by amfAR, The Foundation for AIDS Research. By expanding intellectual property…

Read More

Cher joins Felipe Diniz and Jean Paul Gaultier as honorees at AmfAR’s 5th Inspiration Gala São Paulo, April 10

NEW YORK, N.Y.— amfAR, The Foundation for AIDS Research will return to Brazil for its fifth annual Inspiration Gala São Paulo presented by Harry Winston. The gala will again be held at the home of Dinho Diniz, hosted by Naomi Campbell and will feature tributes to Felipe Diniz and Jean Paul Gaultier. Diniz, who will receive the amfAR Inspiration Award, has been vital to the success of amfAR’s…

Read More

amfAR report examines controversial pricing of hepatitis C treatment

NEW YORK  – Despite important price reductions for some low- and middle-income countries, the exorbitant drug pricing of breakthrough treatments for hepatitis C (HCV) infection will inevitably limit access to the drugs, leading to unnecessary loss of life, according to a new report from amfAR, The Foundation for AIDS Research. While the new drugs have…

Read More

amfAR report examines heavy impact of HIV/AIDS on black gay men in the United States

NEW YORK – The nation’s inability to effectively address HIV infections among Black gay men is one of the greatest failures of the U.S. HIV/AIDS response, according to a new report released today by amfAR, The Foundation for AIDS Research. Despite their disproportionate risk, the report finds that efforts to address the HIV epidemic among…

Read More